Jiangxi Huashi Pharmaceutical Co., Ltd. is moving ahead with a major renovation and expansion of its manufacturing operations, proposing a 1,100 tonnes-per-annum high-efficiency, safe and low-toxicity pesticide technical project at its facility in Fenghua County, Yichun City, Jiangxi Province.
The environmental impact report for the project was proposed for acceptance on July 27, 2026. The planned investment is $5.87 million (RMB 39.87 million) and marks a strategic shift for the company, which intends to discontinue several pharmaceutical and intermediate products at the existing site while expanding its presence in the crop protection chemicals business.
Under the new product plan, the facility will produce seven pesticide-related products with a combined annual capacity of 1,100 tonnes. The portfolio will include 100 tonnes of 95 per cent metconazole, 300 tonnes of 98 per cent prothioconazole, 400 tonnes of 97 per cent picoxystrobin, 150 tonnes of 97 per cent epoxiconazole, 50 tonnes of 98 per cent bixafen, 50 tonnes of a dichloromethylene intermediate and 50 tonnes of 96 per cent benzovindiflupyr.
The capacity mix places a strong emphasis on fungicides, particularly prothioconazole and picoxystrobin, which account for a significant share of the proposed output. The investment comes as Chinese agrochemical manufacturers continue to expand production capacity for several established and high-demand active ingredients, although industry tracking has also pointed to increasing concerns over concentrated capacity additions and potential oversupply in some product categories.
As part of the renovation, Jiangxi Huashi will phase out production of six pharmaceutical and intermediate products currently manufactured at the facility. These include a 60-tonne-per-annum chlorophenyl-fluorophenyl propene intermediate, 35 tonnes of a chlorophenyl cyclopropylethyl oxirane product, 10 tonnes of dapagliflozin, 100 tonnes of a chlorocyclopropyl triazolidine compound, 20 tonnes of loxoprofen sodium and 10 tonnes of rebamipide.
The company will retain only its existing 20-tonne-per-annum 3-methoxy-2-[2-(trifluoromethyl)-2-pyridyloxymethyl]phenyl acrylic acid intermediate operation from the earlier production portfolio.
The project reflects a broader repositioning of Jiangxi Huashi from a manufacturer with exposure to pharmaceutical and pesticide intermediates towards a more focused pesticide technical business. The company, founded in 2008, has a registered capital of $4.71 million (RMB 32 million) and supplies pharmaceutical and pesticide intermediates to markets including Europe, South America, Japan and South Korea.
Jiangxi Huashi already has technical expertise linked to the crop protection sector, including patented work relating to intermediates used in epoxiconazole production.
The proposed expansion also highlights the continuing investment momentum within China’s agrochemical manufacturing industry. Recent capacity tracking has shown sustained investment in fungicides such as prothioconazole, picoxystrobin and related active ingredients, even as the growing number of manufacturing projects raises questions about future competition and pricing pressure.
For Jiangxi Huashi, however, the project represents more than an incremental capacity addition. By discontinuing a range of pharmaceutical and intermediate products and concentrating resources on pesticide technicals, the company is reshaping its production base around a portfolio of fungicides and advanced crop protection ingredients. If completed as planned, the 1,100-tonne facility will strengthen Jiangxi Huashi’s position in China's increasingly competitive agrochemical manufacturing landscape.
